Compare CLLS & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | ALTO |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 420.7M |
| IPO Year | 2014 | 2005 |
| Metric | CLLS | ALTO |
|---|---|---|
| Price | $3.35 | $5.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 36.3K | ★ 2.8M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 119.51 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $917,927,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | $0.98 | $0.43 |
| P/E Ratio | ★ N/A | $111.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.62 | $0.92 |
| 52 Week High | $5.48 | $6.11 |
| Indicator | CLLS | ALTO |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 54.70 |
| Support Level | $2.86 | $4.27 |
| Resistance Level | $3.41 | $5.98 |
| Average True Range (ATR) | 0.16 | 0.36 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 86.96 | 57.92 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.